BCM
KATE

Bayesian Capital Management’s Kate Spade & Company KATE Stock Holding History

Bayesian Capital Management’s Portfolio KATE Stock Details KATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-41,000
Closed -$952K – 678
2017
Q1 		$952K Buy
+41,000
New +$857K 0.45% 44

Other funds holding KATE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bayesian Capital Management's KATE Position: Q2 2017 in Review

Bayesian Capital Management sold out of Kate Spade & Company (KATE) in Q2 2017, closing a stake of 41,000 shares — an estimated $952K sold.

Bayesian Capital Management first reported a position in KATE in Q1 2017 and held it in 1 quarter. The position peaked at $952K in Q1 2017. 211 funds tracked by Wall St. Rank hold KATE as of Q2 2017.

  • Bayesian Capital Management reported no remaining Kate Spade & Company position as of Q2 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 41,000 Kate Spade & Company shares in Q2 2017, an estimated $952K.
  • Bayesian Capital Management first reported a position in Kate Spade & Company in Q1 2017 and held it in 1 quarter.
  • Bayesian Capital Management's Kate Spade & Company position peaked at $952K in Q1 2017.
  • 211 funds tracked by Wall St. Rank held Kate Spade & Company as of Q2 2017.

Based on Bayesian Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.